The Latest Cardiac and Vascular News
MARLBOROUGH, Mass., Jan. 3, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the fourth quarter ended December 31, 2017 on Thursday, February 1, 2018 at 8:00 a.m. EST. The call […]
MARLBOROUGH, Mass., Dec. 21, 2017 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Goldman Sachs Healthcare CEOs Unscripted Conference on Thursday, January 4, 2018 in Boston, MA. Mike Mahoney, chairman and chief executive officer, will participate in a 30-minute question-and-answer session with […]
MARLBOROUGH, Mass., Nov. 28, 2017 /PRNewswire/ — Boston Scientific (NYSE: BSX) announces a delay to previously communicated timelines for commercialization of the LOTUS Edge™ Aortic Valve System* in Europe and the U.S. After initiating a voluntary recall for the LOTUS and LOTUS Edge Aortic Valve Systems […]
MARLBOROUGH, Mass., Nov. 27, 2017 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) will participate in the Citi 2017 Global Healthcare Conference on December 7, 2017 in New York. Kevin Ballinger, executive vice president and president, interventional cardiology, and Susie Lisa, vice president, investor relations, will participate in a […]
MARLBOROUGH, Mass., Nov. 6, 2017 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) will participate in the 26th Annual Credit Suisse Healthcare Conference on November 7, 2017 in Scottsdale, Arizona. Joe Fitzgerald, executive vice president & president, rhythm management, and Susie Lisa, vice president, investor relations, will participate […]
DENVER and MARLBOROUGH, Mass., Nov. 2, 2017 /PRNewswire/ — Boston Scientific (NYSE: BSX) announced final five-year outcomes data from the PREVAIL study of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device today during a late-breaking clinical trial session at the 29th Transcatheter Cardiovascular Therapeutics (TCT), the […]
MARLBOROUGH, Mass., Oct. 26, 2017 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated sales of $2.222 billion during the third quarter ended September 30, 2017. This represents growth of 5.6 percent on a reported basis and 5.7 percent on an operational basis (excludes the impact of […]
MARLBOROUGH, Mass., Oct. 23, 2017 /PRNewswire/ — Boston Scientific (NYSE: BSX) today announced key data that will be presented at the 29th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, in Denver, on October 29 – November 2. WATCHMAN™ Left Atrial […]
Boston Scientific shared the 3-year MAJESTIC DES data online at CardioVascular and Interventional Radiology MAJESTIC 3-Year Data Published for Boston Scientific’s Eluvia DES, by Endovascular Today October 11, 2017—The 3-year results of the MAJESTIC first-in-human study of the Eluvia paclitaxel-eluting vascular stent […]
MARLBOROUGH, Mass., Oct. 2, 2017 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced a definitive agreement to acquire Apama Medical Inc., a privately-held company that is developing the Apama Radiofrequency (RF) Balloon Catheter System for the treatment of atrial fibrillation (AF). […]
